G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,825,165 | +30.2% | 800,511 | +146.7% | 0.00% | +50.0% |
Q1 2024 | $1,401,693 | +871.7% | 324,466 | +586.0% | 0.00% | – |
Q4 2023 | $144,253 | -74.9% | 47,296 | -77.9% | 0.00% | -100.0% |
Q1 2023 | $574,120 | -73.6% | 214,224 | -46.4% | 0.00% | -83.3% |
Q4 2022 | $2,172,114 | +91.0% | 400,021 | +339.5% | 0.01% | +71.4% |
Q3 2022 | $1,137,000 | +249.8% | 91,009 | +38.2% | 0.01% | +250.0% |
Q2 2022 | $325,000 | +157.9% | 65,838 | +296.1% | 0.00% | +100.0% |
Q1 2022 | $126,000 | -60.7% | 16,622 | -47.1% | 0.00% | -50.0% |
Q4 2021 | $321,000 | – | 31,447 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |